Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Oral tirzepatide is not the wrong choice in the right circumstances
Got my prescription in a very short time
and the Pharmacy Compounding Advisory Committee subsequently voted against adding it to the Category 1/503A bulk drug substances list at its late-2024 meetings, leaving it without a confirmed legal compounding pathway at that time
In that situation the responsible default is not assume it is fine unless proven harmful
Semaglutide and tirzepatide both bill using J3490 (Drug, Not Otherwise Classified) or J3590 (Non-Covered Drug) depending on the payer
US$ 27.30
US$ 22.31
US$ 24.77
US$ 20.99
US$ 23.37
